Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

HealthStream Q1 Profit Declines

RELATED NEWS
Trade HSTM now with 

HealthStream Inc. (HSTM: Quote) reported first-quarter net income of $1.4 million or $0.05 per share, down from $1.5 million or $0.07 per share last year

On average, analysts polled by Thomson Reuters expected earnings of $0.06 per share for the quarter. Analysts' estimates typically exclude special items.

Revenue for the quarter rose 28 percent to $23.7 million from $18.5 million a year ago.

Analysts expected revenues of $22.75 million for the quarter. Looking ahead, the company reiterated its previous guidance and anticipates a 21-25 percent increase in consolidated revenues for the full year 2012 compared to the previous year. The company expects a 20-26 percent increase in year-over-year operating income .

Click here to receive FREE breaking news email alerts for Healthstream Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After initially showing a lack of direction, stocks have moved mostly higher over the course of the trading day on Friday. With the gains on the day, the markets are extending the upward trend seen over the past several sessions. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections. While the Commerce Department released a report on Friday showing a modest increase in new home sales in the U.S. in the month of September, the uptick came from a significantly downwardly revised level in August.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.